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ABSTRACT 
 
Metabolic and oxidative stresses induce physiological adaptation processes, disrupting a 
finely tuned, coordinated network of gene expression. To better understand the interplay 
between the mRNA and miRNA transcriptomes, we examined how two distinct metabolic 
stressors alter the expression profile of human dermal fibroblasts.  
Primary fibroblast cultures were obtained from skin biopsies of 17 healthy subjects. 
Metabolic stress was evoked by growing subcultured cells in glucose deprived galactose 
enriched (GAL) or lipid reduced cholesterol deficient (RL) media, and compared to parallel-
cultured fibroblasts grown in standard (STD) medium. This was followed by mRNA expression 
profiling and assessment of > 1,000 miRNAs levels across all three conditions. The miRNA 
expression levels were subsequently correlated to the mRNA expression profile. 
Metabolic stress by RL and GAL both produced significant, strongly correlated 
mRNA/miRNA changes. At the single gene level four miRNAs (miR-129-3p, miR-146b-5p, miR-
543 and miR-550a) showed significant and comparable expression changes in both 
experimental conditions. These miRNAs appeared to have a significant physiological effect on 
the transcriptome, as nearly 10% of the predicted targets reported changes at mRNA level. The 
two distinct metabolic stressors induced comparable changes in the miRNome profile, 
suggesting a common defensive response of the fibroblasts to altered homeostasis. The 
differentially expressed miR-129-3p, miR-146b-5p, miR-543 and miR-550a regulated multiple 
genes (e.g. NGEF, NOVA1, PDE5A) with region- and age-specific transcription in the human 
brain, suggesting that deregulation of these miRNAs might have significant consequences on 
CNS function. The overall findings suggest that analysis of stress-induced responses of 
peripheral fibroblasts, obtained from patients with psychiatric disorders, is a promising avenue 
for future research endeavors. 
 
Keywords: human fibroblast, stress, miRNA, mRNA, profiling, lipid, galactose, qPCR 
  
  
3 
 
INTRODUCTION 
Postmortem brain studies of psychiatric disorders show complex transcriptome profile 
changes that encompass both miRNA and mRNA disturbances [1,2]. Yet, these studies face 
considerable confounds, limiting mechanistic and molecular investigation into the causality of 
the observed changes. The uniquely human occurrence of major psychiatric disorders and the 
absence of bona fide animal models [3,4,5] underscore the need for analyzing human tissue. 
However, the usefulness of post-mortem brain tissue is limited primarily to static measures, 
such as gene expression analysis. Patient fibroblasts, due to their abundance, availability, and 
neuron-like receptor and protein expression are appealing alternative in vitro models for 
functional analysis of brain disorders [6,7]. 
Stress is a strong modulator of gene expression [8]. In vitro, glucose-depleted, 
galactose-supplemented medium is a widely used metabolic stress treatment in fibroblast 
cultures [9]: glucose depletion increases the level of reactive-oxygen species (ROS) which 
results in elevated, compensatory glutathione production [7]. Yet, over a prolonged time 
starvation results in reduction of NADPH, limiting the efficacy of the glutathione protection to the 
cells. In contrast, reduction in the exogenous cholesterol is a different kind, but related 
metabolic stress: to maintain their membrane structure and survive, fibroblasts are forced to 
synthesize their own cholesterol, stressing their metabolic machinery [10]. These two metabolic 
stress models are likely to share common characteristics: there is an increased rate of glucose 
incorporation into lipid when cells are switched into lipid-deficient medium [11] and C14 
galactose incorporates into galactolipids [12]. Therefore, both would be expected to manifest 
common disturbances in the gene expression machinery.  
Micro-RNAs (miRNA) are 18-22 nucleotide long fine-tuning regulators of gene 
expression and protein production [13]. Thousands of miRNAs are encoded in the human 
genome, controlling the function of approximately 50% of our genes. miRNA expression is 
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tissue, environment and individual specific [14]. A single miRNA can regulate the expression of 
hundreds of mRNAs, cause their degradation, destabilization, stocking or transport.  
The present study aimed to answer three questions. First, do the different metabolic 
stressors alter the miRNA expression profile of human fibroblasts? Second, are the miRNA 
expression profiles similar between two different metabolic stressors? Finally, do the miRNA 
expression changes result in changes at the mRNA level? Importantly, these studies provide 
critical baseline data for similar experiments that will be performed on fibroblasts from patients 
with schizophrenia, major depression and bipolar disorder. 
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MATERIALS AND METHODS 
 
ETHICS STATEMENT 
The Vanderbilt University Institutional Review Board (IRB) approved the study and written 
informed consent was obtained from all study participants before any procedures were 
conducted. 
 
HUMAN FIBROBLAST CELL CULTURES 
Specimens for fibroblast cultures were obtained by skin biopsies (~ 1 x 2 mm) from 17 
healthy subjects (4 males and 13 females) (Supplemental Material 1) as described previously 
[15]. Exclusion criteria included any DSM-IV diagnosis [16] or any medical condition that would 
preclude the biopsy.  
All fibroblast samples used in this experiment were cultured between passages 5 and 10 
using Dulbecco`s modified Eagle`s medium™ (DMEM; Mediatech, Manassas, VA, USA) 
containing 25mM glucose, 1 mM sodium pyruvate supplemented with 2 mM L-glutamine 
(Mediatech), 10% fetal bovine serum (FBS; Thermo Scientific HyClone, Logan, UT, USA) and 
antibiotic/antimycotic solution (A/A; Invitrogen) at 37 ºC and 5% CO2. The cells were cultured 
simultaneously under same conditions until reaching confluence, trypsinized and counted. 
A single cell line from each individual was divided into three plates (plating density 
1.2x106 cells/plate) and after overnight adherence, the medium was changed into 3 different 
conditions. All cultures were grown for 7 days, with a media change every 2 days. (Figure 1) 
and were grown in: 1) lipid reduced (RL) medium (DMEM supplemented with lipid reduced FBS 
(Thermo Scientific HyClone, Logan, UT, USA)); 2) galactose-containing (GAL) medium (DMEM 
deprived of glucose (Mediatech) supplemented with 10mM galactose) and 3) standard, glucose-
containing (STD) medium. The medium was changed three times a week. Cell growth and 
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proliferation were not affected by GAL or RL treatment. After one week the cells were washed 
with ice-cold PBS twice, trypsinized, pelleted (700g for 8 min on 18 ºC) and stored on -80 ºC 
until the RNA isolation. 
 
RNA ISOLATION 
 Total cell RNA and small RNA fractions were isolated from the frozen samples using the 
mirVana miRNA isolation Kit (Ambion, Austin, TX) according to manufacturer’s instructions. In 
brief, the pellet was suspended in 600 µl Lysis/Binding Solution, than 60 µl Homogenate 
Additive was added. After 10 min incubation time for total RNA isolation 1.25x volume of 100% 
ethanol was added to the aqueous phase and the supernatant was purified using the proprietary 
solutions provided by the manufacturer. Finally the total RNA was collected with  100 µl Elution 
Solution. For small RNA isolation we added on-thrid volume of 100% ethanol to the aqueous 
phase and two-thrid volume of 100% ethanol to the flow-through. The small RNA specied were 
collected from the filter with 100 µl Elution Solution. Agilent 2100 Bioanalyzer was used to 
determine the quality and size distribution of the total RNA and small RNA fractions. All samples 
showed a RNA Intergity Number (RIN) >8.0. The samples were stored on -80 ºC until used. 
 
DNA MICROARRAY and miRNome PCR ARRAY 
 mRNA expression: mRNA levels were examined with the GeneChip HT HG-U133+ PM 
Array Plate (Affymetrix, Santa Clara, CA, USA). cDNA synthesis from total RNA, IVT, labeling 
and hybridization were performed according to manufacturer`s protocol. 
 miRNA expression: From small RNA samples cDNA was prepared with miScript II RT Kit 
(Qiagen, Valencia, CA, USA) using miScript HiSpec Buffer. The DNA was quantified with 
NanoDrop ND-1000 spectophotometer, yielding 693-839 ng/µl. After reverse transcription, the 
individual sample cDNAs were pooled into four groups based the gender and the age. Each 
group contained material from 4-5 individuals. Group 1: males age of 30-48; group 2: females 
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age of 20-25; group 3: females age of 27-40; group 4: females age of 44-52 (Supplemental 
Material 1). The relative amounts of 1008 miRNAs were measured with miRNome miRNA PCR 
Arrays using miScript SYBR Green PCR Kit (Qiagen, Valencia, CA, USA) according to the 
manufacturer`s instructions.  
 
VALIDATION OF mRNA FINDINGS 
Based on our pathway analyses we selected a panel of 10 lipid biosynthesis genes, and 
validated the mRNAs using qPCR on the individual control, GAL-treated and RL-exposed 
samples (n=18). Total RNA (500 ng) from each sample was reverse transcribed to cDNA using 
RT2 First Strand Kit (Qiagen) using the instructions of the manufacturer. Custom-designed RT2 
Profiler PCR Arrays (Qiagen) were provided in 96-well plate format and contained primer 
assays for 10 focused genes (SCD, FABP3, DHCR7, INSIG1, QPRT, HMGCR, HMGCS1, 
LDLR, FADS1, FADS2) and 2 housekeeping genes (ACTB and GAPDH). RT2 Profiler PCR 
Arrays assays were performed on the real-time cycler ABI Prism 7300 System (Applied 
Biosystems). The exported Cts were analyzed using SABiosciences PCR Array Data Analysis 
Template Excel software and compared across STD-RL and STD-GAL groups using a paired 
experimental design.  
 
VALIDATION OF miRNA FINDINGS 
  22 miRNAs were selected for follow up on the 17 individual samples (hsa-miR-146b-5p, 
hsa-miR-550a, hsa-miR-129-3p, hsa-miR-214, hsa-miR-21, hsa-miR-22, hsa-miR-132, hsa-
miR-376c, hsa-miR-19a, hsa-miR-195, hsa-miR-181a, hsa-miR-486-5p, hsa-miR-377, hsa-miR-
424,hsa-miR-542-3p,hsa-miR-22, hsa-miR-103a, hsa-miR-376b, hsa-miR-29b, hsa-miR-185, 
hsa-miR-564, hsa-miR-34a). The assays was identical to the one used on the pooled samples 
described above.   
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DATA ANALYSIS: 
Differential expression: 
For the mRNA studies, after standard image segmentation of the microarray images, 
RMA normalization was performed using GenePattern software [17]. At the individual level, the 
gene was considered to be differentially expressed if it showed an absolute average log ratio 
|ALR| ≥ 0.378 and p-value ≤ 0.01 between the experimental and control conditions. Pathway 
analyses were performed using GenePattern – Gene Set Enrichment Analysis (GSEA) [18] and 
its BioCarta Database.  
For miRNA expression quantification comparative Ct method was used with SNORD61, 
SNORD68, SNORD72, SNORD95, SNORD96A and RNU6-2 as housekeeping genes. A 
miRNA was considered differentially expressed if it showed a |ΔΔCt| ≥ 0.583 and both a 
groupwise and pairwise p value of p ≤ 0.05 between the experimental and control condition. 
These parameters were chosen based on previously analyzed datasets 
(PMID:16308155; http://dx.doi.org/10.2174/138920206776389739), and followed up by qPCR 
validation. 
Hierarchical clustering and calculation of correlation:  
For both the mRNA and miRNA data two-way unsupervised clustering using Euclidian 
distance was performed using the GenePattern software package [17]. For mRNA, this was 
performed  using the RMA - normalized log2 gene expression values from each individual 
sample, while for the miRNA the ΔCt values were used. Correlations were calculated in MS-
Excel 2010 using Pearson coefficient.  
Identification of miRNA targets:  
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To identify the potentially affected mRNAs by the four miRNAs that were changed in 
both the GAL- and RL-exposed cultures (miR-129-3p, miR-146b-5p, miR-543 and miR-550a), 
we searched the miRDB online database [19] and established the list of their potential targets. 
 
COMPARISON TO BRAIN EXPRESSION 
To test the relevance of our fibroblast findings in context of human brain disorders, we 
examined the mRNA expression of putative miR-129-3p, miR-146b-5p, miR-543 and miR-550a 
targets in the developing human brain [31]. 
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RESULTS 
METABOLIC STRESS-INDUCED mRNA CHANGES 
 Our mRNA expression profiling revealed 2063 differentially expressed genes in the GAL 
group compared to the matched controls. Of these, 1117 (54.1%) were up-regulated 
(Supplemental Material 2A), while 946 (45.9%) showed downregulation.  These regulated 
gene products were involved in cell cycle, apoptosis, inflammatory response and mRNA 
processing related pathways, and in metabolic adaptation. RL treatment had also a widespread 
effect on the transcriptome. 984 gene transcripts were affected by the RL treatment, with 640 
mRNAs increased (65.0%) and 344 (35.0%) transcripts repressed (Supplemental Material 2B). 
Two-way unsupervised hierarchical clustering provided a good separation of samples based on 
the treatment condition (Supplemental Material 3AB). Pathway analysis with BioCarta 
classification revealed enrichment of 18 groups of transcripts in the GAL condition (Table 1A), 
while in the RL condition, the analysis revealed enrichment in 12 pathways and transcript 
repression in 3 pathways (Table 1B). Notably, 4 of these pathways were commonly upregulated  
in both the GAL and RL condition: peroxisome proliferator-activated receptor α (PPARA), 
carbohydrate response element binding protein 2 (CHREBP2), influence of Ras and Rho 
proteins on G1 to S Transition (RACCYCD) and stress induction of HSP regulation (HSP27).  
As there was a significant enrichment of lipid biosynthesis genes in the fibroblast as a result of 
exposure to RL and GAL conditions, we decided to validate a panel 10 commonly upregulated 
genes (SCD, FABP3, DHCR7, INSIG1, QPRT, HMGCR, HMGCS1, LDLR, FADS1, FADS2). 
qPCR assessment of expression validated 9 out of 10 transcript changes in both RL and GAL 
conditions (all except HMGCR, which showed the same directionality and magnitude of change, 
but did not reach statistical significance) (Supplemental Material 4) and revealed a high 
correlation between the microarray and qPCR results (GAL-STD comparison: r=0.92; RL-STD 
comparison: r=0.72) (Figure 2). 
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miRNA EXPRESSION IN RESPONSE TO METABOLIC STRESS 
 We found that in human fibroblasts 45 miRNAs were differentially expressed due to the 
GAL treatment (Table 2 A,B) (|ΔΔCt| ≥ 0.583; p≤0.05), with approximately same number of 
miRNAs increased and decreased (24 miRNAs and 21 miRNAs, respectively). The RL 
treatment affected 34 miRNAs, with more prominent downregulation than upregulation (27 and 
7, respectively). When compared to the control cultures, four miRNAs showing significant 
differential expression overlapped in the two metabolic stress conditions (GAL, RL) (Figure 3). 
However, the overall pattern of miRNA profiles between the two stressors was strong: the 
differentially expressed miRNA’s in the GAL condition, when correlated with their expression 
level in the RL condition, showed a significant correlation (r=0.71, p<0.001) (Figure 4A). 
Similarly, the expression levels of differentially expressed miRNA’s in the RL condition were 
correlated with the expression levels observed in the RL condition (r=0.65, p<0.005) (Figure 
4B). Furthermore, the combined list of these miRNA expression changes, when subjected to a 
two-way unsupervised hierarchical clustering, perfectly separated out the CNT, GAL and RL 
conditions (Figure 5).  Thus, while the most changed miRNAs were not identical between the 
GAL and RL, the overall pattern suggested a comparable miRNA response between the two 
very different metabolic stressors. 
 As the initial screening was performed on 4 pools of samples which could theoretically 
bias our data, we wanted to validate the expression of 22 miRNAs on our 17 individual samples. 
In this follow-up study the initial miRNA findings on the pooled samples showed the expected 
expression pattern on the individual experimental samples (Figure 6).  
 
CORRELATION OF miRNA WITH mRNA EXPRESSION 
 To establish how metabolic stress-induced miRNAs affect the mRNA transcriptome, we 
focused our attention on the four significantly changed miRNAs that overlapped between the 
GAL- and RL-treatment: miR-129-3p, miR-146b-5p, miR-543 and miR-550a. To identify the 
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target mRNAs of these miRNAs we established the list of their potential targets using the 
miRDB online data base. The database revealed 211 putative mRNA targets of miR-129-3p, 
243 mRNA targets of miR146b-5p, 129 mRNA targets of miR-550a, and 921 targets for miR-
543 (Supplemental Material 5). Of the combined 1504 potential targets 140 mRNAs showed 
significant change at gene expression level (Table 3A-C). It is noteworthy that multiple target 
genes showed significantly altered transcription levels in both the GAL- and RL-treated human 
fibroblast cultures, further arguing for a consistent effect of the two different metabolic stressors.   
Finally, we attempted to establish if any of these putative mRNA targets of miR-129-3p, 
miR-146b-5p, miR-543 and miR-550a showed spatio-temporal regulation in the developing 
human brain [31]. Fourteen such transcripts were identified (rfx7, syt14, nova1, kiaa1199, 
spata13, osbpl8, exph5, ngef, pag1, acyp1, pde5a, adamtsl1, cyp26b1 and pag1) 
(Supplemental Material 6), suggesting that these targets should be the primary focus of further 
follow-up examinations in the brain tissue of neurodevelopmental disorders.   
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CONCLUSIONS 
This study established the mRNA and miRNA expression changes in human fibroblast 
cell cultures in response to two nutrition-based metabolic stress paradigms. We found that 1) 
glucose depleted, galactose supplemented and a lipid reduced, cholesterol depleted medium 
produced widespread mRNA and miRNA changes in human fibroblasts; 2) while the most 
significantly changed miRNAs showed variation, the overall miRNA changes across the two 
metabolic stress conditions showed considerable similarity; 3) it appears that changes in miRNA 
expression contributed considerably to altered mRNA expression profile in both the GAL and RL 
conditions and 4) we identified 4 significantly changed miRNAs (miR-129-3p, miR-146b-5p, 
miR-543 and miR-550a) that are likely to be important mediators of multiple types of metabolic 
stress.  
Using the individual transcript assessment approach, we identified only four significantly 
changed miRNAs (miR-129-3p, miR-146b-5p, miR-543 and miR-550a) common to both 
metabolic stressors. Yet, this is not surprising, as transcripts work in networks: while we 
observed considerable differences in the most changed miRNAs of the GAL- and RL-treated 
fibroblasts, the overall miRNA profile of the two stressors was strikingly similar. Furthermore, 4 
metabolic stress-related transcript pathways (PPARA, CHREBP2, RACCYCD, and HSP27) 
were upregulated in both GAL and RL-exposed cultures, suggesting that this common signature 
is present both at the miRNA and mRNA level. This came as a surprise, as the two stressors 
acts through distinct mechanisms: the GAL condition primarily creates oxidative radicals through 
starvation [7], while the RL conditions forces the cells into a metabolic overdrive [10]. Based on 
these findings we propose that metabolic stress, regardless of the type of the insult, might have 
a common miRNome and mRNA signature, and this common signature perhaps represents a 
non-specific resilience response, helping the cells to adapt and survive.  
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Our results also suggest that the four changed miRNAs alone appeared to be able to 
regulate the mRNA expression of 52 target genes, arguing that miRNA regulation of the 
transcriptome might be a significant contributor to metabolic stress-induced cellular responses. 
Unfortunately, miR-543 and miR-550a has not been well studied experimentally, and their 
effects remain mostly unknown. However, mir-129-2 and miR-146b-5p have been a focus of 
multiple investigations to date: mir-129-2 is located next to a CpG island and is methylation-
associated, and the expression of this miRNA can be epigenetically restored by de-methylating 
drugs [20]. Furthermore, mir-129-2 is conserved in vertebrates and regulates the expression of 
CP110, ARP2, TOCA1, ABLIM1 and ABLIM3, thus effectively controlling actin dynamics in the 
cell [21]. Still, miR-146b-5p might be the most important finding of our studies: its expression is 
highly induced by proinflammatory cytokines, with a clear dependency on IFN-γ, potentially via 
the JAK/STAT pathway [22,23]. Furthermore, a decrease of miR-146b-5p has been observed in 
monocytes during obesity, and it was associated with loss of the anti-inflammatory signaling 
action [24]. miR-146b-5p also regulates signal transduction of TGF-β [25], and appears to play a 
critical role in the pathophysiology of various cancers [26,27]. These data suggest that 
metabolic stress might regulate miRNA expression through epigenetic modification, and that the 
two metabolic stressors trigger an inflammation-like response in the stressed cells. However, 
this hypothesis has to be tested more comprehensively in follow-up experiments. 
Finally, we need to emphasize that peripheral biomarkers studies are essential to 
understand the pathophysiology of human brain disorders. Recent studies indicate that 
peripheral biomarkers may aid the diagnosis of psychiatric disorders and help assess treatment 
efficacy [28]. However, obtaining peripheral patient tissues and analyzing them at resting state 
might not be sufficient to reveal the critical deficits, and they must be challenged to reveal the 
full signature of the disease [7,29]. Human dermal fibroblasts as a model system are ideally 
suited for such studies [30], as they have several advantages over the functional assays 
performed on peripheral blood cells: 1) they can be readily propagated without immortalization, 
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2) have a more similar expression profile to brain cells than peripheral blood cells; 3) are 
homogenous and very responsive to a variety of stimuli, and 4) they are minimally affected by 
epigenetic changes, which usually disappear after the 5th culture passage.  
Our results also suggest that metabolic stress in dermal fibroblasts affects genes that 
are important for brain development and homeostasis. The 4 miRNAs with differential 
expression in both the RL and GAL condition (miR-129-3p, miR-146b-5p, miR-543 and miR-
550a) regulated multiple genes (e.g. NGEF, NOVA1, PDE5A)  that show region- and age-
specific transcription in the human brain [31], suggesting that deregulation of these transcripts 
might have significant consequences on brain function, and should be examined in the context 
of neurodevelopmental disorders. Thus, dermal fibroblasts are appealing, readily available 
human biomaterials, allowing to perform controlled, functional and reproducible experiments on 
human tissue. This is especially important for studying major, polygenic psychiatric disorders, 
where postmortem tissue availability is limited and the genetic animal models do not fully 
recapitulate the human disease. This study defined the miRNA/mRNA transcriptome responses 
of fibroblasts to metabolic stress in healthy individuals, and similar studies should be performed 
in diseased patient material – the response of their transcriptome to the metabolic stress will be 
more revealing of pathophysiology than the case-control differences under resting, 
unchallenged conditions. 
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FIGURE LEGENDS (5): 
 
Figure 1. Experimental design. Flowchart representing the sample collection and 
grouping, the experiments and analyses performed. In summary, skin biopsies were collected 
from 17 male and female individuals, and used to establish in vitro fibroblast cultures. Each 
fibroblast culture was then cultured in standard (STD), galactose containing (GAL) or reduced 
lipid (RL) media. DNA microarrays were used to detect the mRNA profile of each individual 
sample in each culture condition. 4-5 samples of similar age and gender were grouped before 
performing miRNA expression profiling with miRNome qPCR arrays. Grouping-sample effects 
were examined in individual samples with custom qPCR arrays containing selected miRNA 
assays. Finally, we preformed correlation analyses between the commonly changed miRNAs 
and their putative mRNA targets. 
Figure 2. qPCR validation of selected mRNA expression changes. 10 transcripts 
were validated using qPCR (SCD, FABP3, DHCR7, INSIG1, QPRT, HMGCR, HMGCS1, LDLR, 
FADS1, FADS2). X- axis denotes microarray-obtained average log2 ratios (ALR), while Y-axis 
denotes actin-normalized -ΔΔCt  values obtained by qPCR. Note that the microarray and qPCR 
data were highly correlated (GAL: r=0.92 p<0.001; RL: r=0.72, p<0.001). For further details, see 
Supplemental Material 4.  
Figure 3. Commonly changed miRNAs in GAL and RL culture conditions. 45 and 
34 miRNAs showed significant change in GAL and RL conditions, respectively (red- decreased; 
blue – increased). Note that the 4 commonly changed miRNAs had the same directionality in 
both GAL and RL conditions, and they were significantly altered in both pairwise (ppval) and 
groupwise (gpval) testing.   
Figure 4. Overall miRNA pattern changes in GAL and RL conditions are highly 
correlated. The 45 miRNAs with significantly changed expression pattern in GAL conditions 
were assessed in the RL samples (A) and the 34 miRNAs with significantly changed expression 
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pattern in RL conditions were assessed in the GAL samples (B). Note that the miRNA pattern 
observed in either metabolic stressor also showed a similar, highly correlated expression 
pattern in the other condition. 
Figure 5. miRNA expression pattern separates the STD, GAL and RL lipid 
conditions.  Two-way unsupervised hierarchical clustering was performed on the expression 
level (ΔCt) of 75 differentially expressed miRNAs. Samples were clustered vertically, miRNAs 
were clustered horizontally. Each colored square represents a normalized gene expression 
level, color coded for increase (red) or decrease (blue) from the mean. Color intensity is 
proportional to magnitude of change. The clustering resulted in a perfect separation of samples 
into three discrete groups corresponding to culture conditions (vertical dendrogram, green STD, 
yellow GAL, and orange RL). 
Figure 6. Correlation of miRNA changes between individual and pooled fibroblast 
samples cultured in GAL (A) and RL (B) conditions. 22 miRNAs were assessed in the 
validation study, with the pooled ΔΔCTs plotted on X axis and the ΔΔCTs from individual 
samples plotted on the Y axis. Each miRNA represents a single data point. The correlation 
coefficient indicates that pooling of the samples did not skew artificially the miRNA pattern 
observed in GAL and RL. 
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TABLES (3): 
Table 1. mRNA transcriptome changes. Microarray gene expression data, subjected 
to BioCarta pathway analysis with GSEA, identified 19 pathways enriched in fibroblasts cultured 
in GAL (A) and 15 in RL (B). The significantly changed BioCarta pathways are ranked by a net 
enrichment score (NES). The number of genes in each pathway is depicted in the Size column. 
Note that there are 4 differentially expressed pathways common for GAL and RL treatment (*). 
Table 2. miRNA expression profile changes in GAL (A) and RL (B) treatment in 
human fibroblasts. Blue - increased expression; Red – reduced expression; ΔΔCt - normalized 
threshold cycle difference between experimental and control samples; gt - groupwise t-test; pt – 
pairwise t-test. The correlations of these data are graphically represented in Figure 3.  
Table 3. miRNA and mRNA expression changes are correlated in human 
fibroblasts. The three commonly changed miRNAs in both GAL and RL conditions were 
correlated with expression changes of 52 putative target mRNAs. A. miR-129-3p target 
changes, B. miR-550a target changes, C. miR-146b-5p target changes. The commonly 
changed mRNAs in both GAL- and RL-medium exposed human fibroblasts are marked with an 
asterisk. 
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SUPPLEMENTAL MATERIAL 
Supplemental Material 1. Human patient information and sample pooling strategy for 
miRNome qPCR arrays. 
Supplemental Material 2. Differentially expressed mRNA transcripts in GAL and their 
expression in the RL condition (A), and differentially expressed mRNA transcripts in RL 
exposure and their expression in the GAL treatment (B).  
Supplemental Material 3. Clustering of differentially expressed mRNA transcripts in 
GAL (A) and RL condition (B). 
Supplemental Material 4. qPCR validation of 10 lipid biosynthesis transcripts commonly 
changed by RL and GAL exposure. 
Supplemental Material 5. Predicted, putative gene targets of the 4 commonly changed 
miRNAs in both metabolic stressors (GAL and RL) using the miRDB online database [19]. 
Supplemental Material 6. Expression profiles of miR-129-3p, miR-146b-5p, miR-543 
and miR-550a targeted mRNAs in the developing human brain [31]. 
 
 
 
 
